Human airway mucus alters susceptibility of Pseudomonas aeruginosa biofilms to tobramycin, but not colistin.

导出 LinkOut

翻译打印收藏纠错

作者： Laura,Müller ^[1] ; Xabier,Murgia ^[2] ; Lorenz,Siebenbürger ^[3] ; Carsten,Börger ^[4] ; Konrad,Schwarzkopf ^[4] ; Katherina,Sewald ^[5] ; Susanne,Häussler ^[1] ; Armin,Braun ^[6] ; Claus-Michael,Lehr ^[7] ; Marius,Hittinger ^[1] ; Sabine,Wronski ^[2]

作者单位： Fraunhofer Institute for Toxicology and Experimental Medicine (Fraunhofer ITEM), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Centre for Lung Research (DZL), Member of the REBIRTH Cluster of Excellence, Nikolai-Fuchs-Straße 1, Hannover, Germany. ^[1] Helmholtz Institute for Pharmaceutical Research (HIPS), Helmholtz Centre for Infection Research, Universitätscampus E8.1, Saarbrücken, Germany. ^[2] Korea Institute of Science and Technology, KIST Europe, Campus E7.1, Saarbrücken, Germany. ^[3] PharmBioTec GmbH, Science Park 1, Saarbrücken, Germany. ^[4] Department of Anaesthesia and Intensive Care, Klinikum Saarbrücken, Winterberg 1, Saarbrücken, Germany. ^[5] Helmholtz Institute for Infection Research, Inhoffenstraße 7, Braunschweig, Germany. ^[6] TWINCORE, Centre for Experimental and Clinical Infection Research, Feodor-Lynen-Straße 7, Hannover, Germany. ^[7] Department of Pharmacy, Saarland University, Campus, Saarbrücken, Germany. ^[8]